COVIREVAC, the French platform for testing vaccine candidates

A one-stop access to the French expertise in vaccinology and to a pool of 25,000 Volunteers for Large-Scale Clinical Trials

International research is being mobilized in order to develop safe and effective vaccines for COVID-19.
At the request of the French government, France – drawing on the excellence of its clinical research in vaccination – has taken steps to help evaluate the most promising vaccine candidates with the deployment of the COVIREIVAC platform [1].

Managed by Inserm [2] with the operational help of F-CRIN, COVIREIVAC federates 24 Clinical Investigation Centers (CICs) located in university hospitals across France, in close collaboration with the College of Teachers in General Practice [3] (General Practitioners Teaching Association) and its 11 000 members. It also involves a network of clinical immunological research labs to ensure immunomonitoring capabilities throughout the trials. The clinical operational aspects of the various university hospitals are coordinated by the Paris Hospital Group AP-HP [4].